Lv3
270 积分 2022-11-04 加入
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
11天前
已完结
USP20-mediated PGAM1 stabilization promotes glycolysis and confers osimertinib resistance in non-small cell lung carcinoma
30天前
已完结
Inhibition of elastin degradation alleviates joint degeneration in aging mice, dogs, and human models
1个月前
已完结
A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6/JAK2/STAT3 signaling pathway in lung adenocarcinoma
1个月前
已完结
Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity
1个月前
已完结
Targeting PGAM1 in cancer: An emerging therapeutic opportunity
1个月前
已完结
ERβ promoted invadopodia formation‐mediated non‐small cell lung cancer metastasis via the ICAM1/p‐Src/p‐Cortactin signaling pathway
1个月前
已完结
ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis
1个月前
已完结
Letter to the editor concerning “Comparison of radiotherapy versus surgical resection following neoadjuvant chemoimmunotherapy in potentially resectable stage III non-small-cell lung cancer: A propensity score matching analysis”
1个月前
已完结
Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer
7个月前
已完结
皖公网安备34019202002308
